Why the study?
Do platelet-aggregation inhibiting drugs prevent thromboembolic events in at-risk patients?
Population
Patients at risk of thromboembolism, including those with unstable angina, post-aortocoronary bypass, and…
Design
Review
Authors
Loading...
Supports aspirin in unstable angina and post-bypass settings; extends prior reviews but leaves optimal regimens open for prospective trials.
Do platelet-aggregation inhibiting drugs prevent thromboembolic events in at-risk patients?
Aspirin and other antiplatelet drugs are effective in preventing arterial thromboembolism across various clinical scenarios, including unstable angina and post-bypass surgery.
Alex S. Callus (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: